# Summary as of Wednesday 14th February 2024



# Future research and recruitment 

Thank you for your continued involvement in user research – your participation is integral to understanding the user experience on ASPeL.  

We are planning to restart the research on the Named Persons journey in the New Year. If you are interested in taking part in this work, or any future work related to ASPeL, please contact Rachel Cholerton, Senior User Researcher, at rachel.cholerton@digital.homeoffice.gov.uk.  
 


Don't forget to check out our [roadmap](https://roadmap.prodpad.com/937455be-8d08-11ed-aa53-2a7db0eb1d9c) to see what's coming next to ASPeL.

Completed Sprint 140(Uakari)
![Evgenia Kononova, upload on en:wiki by user Ipaat on en.wikipedia, Public domain, via Wikimedia Commons](graphs/Male_uakari.jpg)





Uakari fun and interesting facts: The Uakari is characterized by a bright crimson face and a very short tail.
# Completed this Sprint: 140 (Uakari)
1) Interviews with external users: Named Person as-is establishment journey
2) Complete the upgrade test runner to WEbDriver IO v.8, by fixing outstanding stuborn tests.



# Bugs Fixed this Sprint
There were no bugs fixed this Sprint. 








# New Sprint: 141 (Vicuña)


![Evgenia Kononova, upload on en:wiki by user Ipaat on en.wikipedia, Public domain, via Wikimedia Commons](graphs/Male_uakari.jpg)




 
 Uakari fun and interesting facts: The Uakari is characterized by a bright crimson face and a very short tail.

## Planned for Sprint 140 (Uakari)
1) Complete the Pipeline upgrade
2) Finish writing the PIL E development tickets
3) Fully scope the Named People work
4) Fix the Resuable Steps bugs
5) Map out work to get the Keeping animals alive feature ready for development
6) Fully Onboard the new developer and the new Product Manager.
   


## Things to bear in mind
Let us know how we are doing in keeping you informed. We appreciate your feedback on the content of this report.

# Work in progress
1) Update the anitbody generation conditions for all PPL applications using antibody testing.
2) Harm Benefit Upload transfer journey
3) Intention to Refuse improvement for all licences 
   
## Support tickets and known issues
[Link to Support Board](https://collaboration.homeoffice.gov.uk/jira/secure/RapidBoard.jspa?rapidView=1717)





